Beranda › Purpura Trombositopenik Idiopatik › Massachusetts › Boston
Uji klinis Purpura Trombositopenik Idiopatik di Boston, MA
6 studi untuk Purpura Trombositopenik Idiopatik mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Menerima pesertaFase 2
- Beth Israel Deaconess Medical Center, Boston
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Menerima pesertaFase 2
- Beth Israel Deaconess Medical Center, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Menerima pesertaFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
Menerima pesertaStudi observasional
- Massachusetts General Hospital, Boston
Uji klinis Purpura Trombositopenik Idiopatik di kota lain
- Los Angeles, CA7 studi
- Washington, DC6 studi
- Greenville, NC6 studi
- The Bronx, NY5 studi
- Durham, NC4 studi
- Rochester, MN4 studi
- Seattle, WA4 studi
- Houston, TX4 studi
- Portland, OR4 studi
- New Orleans, LA3 studi
- Cedar Rapids, IA3 studi
- Cleveland, OH3 studi
Studi lain di Boston
- Kanker Payudara112 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)85 studi
- Kanker Metastatik63 studi
- Kanker Kolorektal63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.